Infectious Diseases News and Research

RSS
Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

3M introduces Clean-Trace Hygiene Management System for healthcare facilities

3M introduces Clean-Trace Hygiene Management System for healthcare facilities

Merck launches 'Hope Against Hepatitis C' education program

Merck launches 'Hope Against Hepatitis C' education program

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Pfizer presents SA3Ag staphylococcal vaccine Phase 1 trial data at ECCMID/ICC

Pfizer presents SA3Ag staphylococcal vaccine Phase 1 trial data at ECCMID/ICC

Simple ultrasound examination may avoid complex tests for children with urinary tract infection

Simple ultrasound examination may avoid complex tests for children with urinary tract infection

Uganda: First vaccination for GMZ2 malaria vaccine trial

Uganda: First vaccination for GMZ2 malaria vaccine trial

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Researchers report unexpected finding in Staph aureus study in child care facilities

Researchers report unexpected finding in Staph aureus study in child care facilities

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

Roundup: Fla. lawmakers to vote today on Medicaid changes; Calif. court expands deadline for tobacco suits

Roundup: Fla. lawmakers to vote today on Medicaid changes; Calif. court expands deadline for tobacco suits

Filipino children with KD at greater risk for inflammation of heart blood vessels

Filipino children with KD at greater risk for inflammation of heart blood vessels

Roche seeks FDA clearance for fully automated Chlamydia and gonorrhoeae test

Roche seeks FDA clearance for fully automated Chlamydia and gonorrhoeae test

VA and DoD produce new collaboration guidebook on clinical health research

VA and DoD produce new collaboration guidebook on clinical health research

Spotlight on the NDM-1 “superbug” highlights the long-standing but increasingly alarming situation of antibiotic resistance globally

Spotlight on the NDM-1 “superbug” highlights the long-standing but increasingly alarming situation of antibiotic resistance globally

Springer author earns ESCMID recognition for work in clinical microbiology and infectious diseases

Springer author earns ESCMID recognition for work in clinical microbiology and infectious diseases

Opinions: U.S. support for maternal, child health; infection control at borders; the AMFm model; International Affairs budget; organizations supporting women

Opinions: U.S. support for maternal, child health; infection control at borders; the AMFm model; International Affairs budget; organizations supporting women

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.